The store will not work correctly when cookies are disabled.
4-(5-((2-chlorophenyl)amino)-6-fluoro-1H-indazol-1-yl)-N-methylthiophene-2-carboxamide
ID: ALA4874134
PubChem CID: 156155311
Max Phase: Preclinical
Molecular Formula: C19H14ClFN4OS
Molecular Weight: 400.87
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CNC(=O)c1cc(-n2ncc3cc(Nc4ccccc4Cl)c(F)cc32)cs1
Standard InChI: InChI=1S/C19H14ClFN4OS/c1-22-19(26)18-7-12(10-27-18)25-17-8-14(21)16(6-11(17)9-23-25)24-15-5-3-2-4-13(15)20/h2-10,24H,1H3,(H,22,26)
Standard InChI Key: XMMMCYBZGARUKP-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
30.7190 -6.6283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4308 -6.2156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0071 -6.2156 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.7190 -7.4496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1836 -6.5531 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.7345 -5.9416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3218 -5.2298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5184 -5.3998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6541 -4.4791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7931 -3.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2423 -3.7715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5365 -3.4954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4526 -4.3151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1200 -4.7978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8719 -4.4579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9522 -3.6347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2838 -3.1597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7004 -3.2969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.7799 -2.4795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5279 -2.1418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6076 -1.3251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9384 -0.8488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1916 -1.1907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1113 -2.0064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1954 -2.6231 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
35.5396 -4.9390 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.0071 -5.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
1 4 2 0
2 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 2 2 0
7 9 1 0
9 13 1 0
12 10 1 0
10 11 2 0
11 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
16 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
20 25 1 0
15 26 1 0
3 27 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 400.87 | Molecular Weight (Monoisotopic): 400.0561 | AlogP: 4.98 | #Rotatable Bonds: 4 |
Polar Surface Area: 58.95 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.15 | CX LogP: 4.25 | CX LogD: 4.25 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.51 | Np Likeness Score: -1.92 |
References
1. Feng Y, Park H, Ryu JC, Yoon SO.. (2021) N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors., 12 (10.0): [PMID:34676036] [10.1021/acsmedchemlett.1c00334] |